Patent ID: 6902890
Filing Date: 2005-06-07
Classification: A61K,C07K,C12Q,G01N

Abstract:
1. A method for diagnosing the presence of cancer in a patient comprising: (a) determining levels of Lng108 in cells, tissues or bodily fluids in a patient; and (b) comparing the determined levels of Lng108 with levels of Lng108 in cells, tissues or bodily fluids from a normal human control, wherein an increase in determined levels of Lng108 in said patient versus normal human control is associated with the presence of cancer and wherein Lng108 comprises a polynucleotide of SEQ ID NO:1 or 2, a polynucleotide which, due to degeneracy in genetic coding, comprise variations in nucleotide sequence as compared to SEQ ID NO: 1 or 2, but which still encode the same protein, or a protein encoded by a polynucleotide sequence of SEQ ID NO:1 or 2.